2016
DOI: 10.1016/j.yrtph.2016.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Influence of the uncertainty in the validation of PBPK models: A case-study for PFOS and PFOA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 43 publications
0
18
0
Order By: Relevance
“…Physiologically based toxicokinetic (PBTK) models incorporating absorption, distribution, metabolism, and excretion metrics have been developed to assess the toxicokinetic of PFOS and PFOA in various animal models, including fish and mammals (Andersen et al 2006;Tan et al 2008;Consoer et al 2014Consoer et al , 2016Fabrega et al 2014Fabrega et al , 2016Cheng and Ng 2017;Khazaee and Ng 2018). Such models are particularly useful for assessing the influence of membrane transporters and revealing important challenges in equilibrium modeling of PFAS bioaccumulation.…”
Section: Pfas Bioaccumulation Modelingmentioning
confidence: 99%
“…Physiologically based toxicokinetic (PBTK) models incorporating absorption, distribution, metabolism, and excretion metrics have been developed to assess the toxicokinetic of PFOS and PFOA in various animal models, including fish and mammals (Andersen et al 2006;Tan et al 2008;Consoer et al 2014Consoer et al , 2016Fabrega et al 2014Fabrega et al , 2016Cheng and Ng 2017;Khazaee and Ng 2018). Such models are particularly useful for assessing the influence of membrane transporters and revealing important challenges in equilibrium modeling of PFAS bioaccumulation.…”
Section: Pfas Bioaccumulation Modelingmentioning
confidence: 99%
“…However, in the case of the specific populations, such as developing fetuses, growing infants, and young children, whose chemical metabolizing systems (glucuronidation activity) are underdeveloped, even moderate exposure can lead to higher internal concentration of BPA [32,33]. In recent years, use of physiologically based pharmacokinetic (PBPK) modelling has been quite popular in human health risk assessment [34,35]. Most publications addressed PBPK modelling of BPA adult exposure [33,36].…”
Section: Occurrence Of Edcs In Milk and Toxicokineticsmentioning
confidence: 99%
“…4Where, Ci is the concentration in the tissue i (ng/L), Qi is the blood flow in the tissue i (L/h), Ca is the arterial concentration (ng/L), Ki:p is the partition coefficient of tissue i, and Vi is the volume of the tissue i (L). Detail description of PBPK model can be found in our other publications (Fabrega et al, 2014;Fàbrega et al, 2016).…”
Section: Pfos Pbpk (A Case Study)mentioning
confidence: 99%
“…Dose reconstruction approach has been used, so that the given equivalent oral dose will provide the AUC in the brain that matches the AUC for the 12 different in-vitro doses (6 for 24hr and 6 for 48hr), a similar approach has been used in the previous study (Thiel et al, 2017). The oral equivalent doses were estimated to be way higher, as the PFOS concentration reaching to the brain was found to be relatively very low (Fabrega et al, 2014;Fàbrega et al, 2016). The estimated oral equivalent doses for the corresponding in-vitro doses are provided in Table 1.…”
Section: Ivive For Dose Equivalencymentioning
confidence: 99%